The Oliver Twist.

The article focuses on the exploitative practices of pharmaceutical companies in inflating drug prices, particularly for rare diseases. Topics include a hedge fund manager's involvement in a plan to manipulate drug prices, the rise of exorbitant pricing strategies by pharmaceutical companies exemplified by Martin Shkreli's actions, the prevalence of orphan drugs and their impact on the industry, and the drug prices in the U.S.